conducted a retrospective cohort study of 186 glioma patients;100 based on the results of the immunochemical assay, the authors showed that glioma patients with a positive variant of the ATRX gene in the non‐epilepsy group were less likely to develop epilepsy than those in the epilepsy group. This evidence concerns the gene ATRX and central nervous system cancer.